Distribution of grey matter atrophy in Huntington's disease patients: A combined ROI-based and voxel-based morphometric study

NeuroImage

Volumn 32, Issue 4, 2006, Pages 1562-1575

  Douaud, G ^a   Gaura, V ^a   Ribeiro, M J ^b   Lethimonnier, F ^b,c   Maroy, R ^b   Verny, C ^d   Krystkowiak, P ^e   Damier, P ^f   Bachoud Levi, A C ^g,h   Hantraye, P ^a,c   Remy, P ^a,h  

^a SERVICE HOSPITALIER FRÉDÉRIC JOLIOT   (France)

^b SERVICE HOSPITALIER FRÉDÉRIC JOLIOT   (France)

^c IFR49   (France)

^d ANGERS UNIVERSITY HOSPITAL   (France)

^e LILLE UNIVERSITY HOSPITAL   (France)

^f NANTES UNIVERSITY HOSPITAL   (France)

^g HENRI MONDOR HOSPITAL   (France)

^h ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

Author keywords

Atrophy; Huntington; Morphometry; Neurodegenerative; ROI; Segmentation; Striatum; VBM; Volumetry

Indexed keywords

BIOLOGICAL MARKER;

ADULT; ANALYTIC METHOD; ARTICLE; BRAIN ATROPHY; BRAIN MAPPING; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CORPUS STRIATUM; CORRELATION ANALYSIS; FEMALE; GLOBUS PALLIDUS; GRAY MATTER; HIGH RISK PATIENT; HUMAN; HUNTINGTON CHOREA; MALE; MORPHOMETRICS; NERVE DEGENERATION; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SUBSTANTIA NIGRA; TISSUE DISTRIBUTION; VOLUMETRY; VOXEL BASED MORPHOMETRIC STUDY;

ADULT; ATROPHY; BASAL GANGLIA; BRAIN; FEMALE; GLOBUS PALLIDUS; HUMANS; HUNTINGTON DISEASE; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NONLINEAR DYNAMICS;

EID: 33748302789     PISSN: 10538119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2006.05.057     Document Type: Article

References (55)

1. Ashburner J., and Friston K.J. Voxel-based morphometry: the methods. NeuroImage 11 (2000) 805-821
2. Ashburner J., and Friston K.J. Why voxel-based morphometry should be used. NeuroImage 14 (2001) 1238-1243
3. Aylward E.H., Li Q., Stine O.C., Ranen N., Sherr M., Barta P.E., et al. Longitudinal change in basal ganglia volume in patients with Huntington's disease. Neurology 48 (1997) 394-399
4. Bachoud-Lévi A.-C., Remy P., Nguyen J.-P., Brugières P., Lefaucheur J.-P., Bourdet C., et al. Motor and cognitive improvements in patients with Huntington's disease after neural transplantation. Lancet 356 (2000) 1975-1979
5. Bloch J., Bachoud-Levi A.C., Deglon N., Lefaucheur J.P., Winkel L., Palfi S., et al. Neuroprotective gene therapy for Huntington's disease, using polymer-encapsulated cells engineered to secrete human ciliary neurotrophic factor: results of a phase I study. Hum. Gene Ther. 15 (2004) 968-975
6. Bookstein F.L. "Voxel-based morphometry" should not be used with imperfectly registered images. NeuroImage 14 (2001) 1454-1462
7. Bots G.T., and Bruyn G.W. Neuropathological changes of the nucleus accumbens in Huntington's chorea. Acta Neuropathol. (Berl.) 55 (1981) 21-22
8. Brett M., Anton J.L., Valabregue R., and Poline J.B. Region of interest analysis using an SPM toolbox. Proc. 8th HBM, Sendai, Japan (2002) (June)
9. Calder A.J., Keane J., Manes F., Antoun N., and Young A.W. Impaired recognition and experience of disgust following brain injury. Nat. Neurosci. 3 (2000) 1077-1078
10. Crum W.R., Griffin L.D., Hill D.L., and Hawkes D.J. Zen and the art of medical image registration: correspondence, homology, and quality. NeuroImage 20 (2003) 1425-1437
11. de la Monte S.M., Vonsattel J.P., and Richardson Jr. E.P. Morphometric demonstration of atrophic changes in the cerebral cortex, white matter, and neostriatum in Huntington's disease. J. Neuropathol. Exp. Neurol. 47 (1988) 516-525
12. Deng Y.P., Albin R.L., Penney J.B., Young A.B., Anderson K.D., and Reiner A. Differential loss of striatal projection systems in Huntington's disease: a quantitative immunohistochemical study. J. Chem. Neuroanat. 27 (2004) 143-164
13. Duchesnay E., Roche A., Riviere R., Papadopoulos-Orfanos D., Cointepas Y., and Mangin J.F. Population classification based on structural morphometry of cortical sulci. Proc. 2th Proc. IEEE ISBI, Arlington, VA (2004) 1276-1279 (Apr).
14. Fennema-Notestine C., Archibald S.L., Jacobson M.W., Corey-Bloom J., Paulsen J.S., Peavy G.M., et al. In vivo evidence of cerebellar atrophy and cerebral white matter loss in Huntington disease. Neurology 63 (2004) 989-995
15. Ginovart N., Lundin A., Farde L., Halldin C., Backman L., Swahn C.G., et al. PET study of the pre- and post-synaptic dopaminergic markers for the neurodegenerative process in Huntington's disease. Brain 120 Pt. 3 (1997) 503-514
16. Giuliani N.R., Calhoun V.D., Pearlson G.D., Francis A., and Buchanan R.W. Voxel-based morphometry versus region of interest: a comparison of two methods for analyzing gray matter differences in schizophrenia. Schizophr. Res. 74 (2005) 135-147
17. Good C.D., Johnsrude I., Ashburner J., Henson R.N., Friston K.J., and Frackowiak R.S. Cerebral asymmetry and the effects of sex and handedness on brain structure: a voxel-based morphometric analysis of 465 normal adult human brains. NeuroImage 14 (2001) 685-700
18. Good C.D., Johnsrude I.S., Ashburner J., Henson R.N., Friston K.J., and Frackowiak R.S. A voxel-based morphometric study of ageing in 465 normal adult human brains. NeuroImage 14 (2001) 21-36
19. Good C.D., Scahill R.I., Fox N.C., Ashburner J., Friston K.J., Chan D., et al. Automatic differentiation of anatomical patterns in the human brain: validation with studies of degenerative dementias. NeuroImage 17 (2002) 29-46
20. Gray J.M., Young A.W., Barker W.A., Curtis A., and Gibson D. Impaired recognition of disgust in Huntington's disease gene carriers. Brain 120 Pt. 11 (1997) 2029-2038
21. Gutekunst C.A., Li S.H., Yi H., Mulroy J.S., Kuemmerle S., Jones R., et al. Nuclear and neuropil aggregates in Huntington's disease: relationship to neuropathology. J. Neurosci. 19 (1999) 2522-2534
22. Halliday G.M., McRitchie D.A., Macdonald V., Double K.L., Trent R.J., and McCusker E. Regional specificity of brain atrophy in Huntington's disease. Exp. Neurol. 154 (1998) 663-672
23. Harris G.J., Aylward E.H., Peyser C.E., Pearlson G.D., Brandt J., Roberts-Twillie J.V., et al. Single photon emission computed tomographic blood flow and magnetic resonance volume imaging of basal ganglia in Huntington's disease. Arch. Neurol. 53 (1996) 316-324
24. Harris G.J., Codori A.M., Lewis R.F., Schmidt E., Bedi A., and Brandt J. Reduced basal ganglia blood flow and volume in pre-symptomatic, gene-tested persons at-risk for Huntington's disease. Brain 122 Pt. 9 (1999) 1667-1678
25. Hedreen J.C., and Folstein S.E. Early loss of neostriatal striosome neurons in Huntington's disease. J. Neuropathol. Exp. Neurol. 54 (1995) 105-120
26. Hennenlotter A., Schroeder U., Erhard P., Haslinger B., Stahl R., Weindl A., et al. Neural correlates associated with impaired disgust processing in pre-symptomatic Huntington's disease. Brain 127 (2004) 1446-1453
27. Herve P.Y., Mazoyer B., Crivello F., Perchey G., and Tzourio-Mazoyer N. Finger hand-arm, handedness and grey matter amount in the Rolando's genu area. NeuroImage 25 (2005) 1133-1145
28. Jernigan T.L., Salmon D.P., Butters N., and Hesselink J.R. Cerebral structure on MRI: Part II. Specific changes in Alzheimer's and Huntington's diseases. Biol. Psychiatry 29 (1991) 68-81
29. Kassubek J., Juengling F.D., Kioschies T., Henkel K., Karitzky J., Kramer B., et al. Topography of cerebral atrophy in early Huntington's disease: a voxel based morphometric MRI study. J. Neurol., Neurosurg. Psychiatry 75 (2004) 213-220
30. Kremer H.P., Roos R.A., Dingjan G., Marani E., and Bots G.T. Atrophy of the hypothalamic lateral tuberal nucleus in Huntington's disease. J. Neuropathol. Exp. Neurol. 49 (1990) 371-382
31. Kremer H.P., Roos R.A., Dingjan G.M., Bots G.T., Bruyn G.W., and Hofman M.A. The hypothalamic lateral tuberal nucleus and the characteristics of neuronal loss in Huntington's disease. Neurosci. Lett. 132 (1991) 101-104
32. Lange H., Thorner G., Hopf A., and Schroder K.F. Morphometric studies of the neuropathological changes in choreatic diseases. J. Neurol. Sci. 28 (1976) 401-425
33. Langston J.W., Widner H., Goetz C.G., Brooks D., Fahn S., Freeman T., et al. Core assessment program for intracerebral transplantations (CAPIT). Mov. Disord. 7 (1992) 2-13
34. Lasker A.G., and Zee D.S. Ocular motor abnormalities in Huntington's disease. Vision Res. 37 (1997) 3639-3645
35. Luders E., Steinmetz H., and Jancke L. Brain size and grey matter volume in the healthy human brain. NeuroReport 13 (2002) 2371-2374
36. Mann D.M., Oliver R., and Snowden J.S. The topographic distribution of brain atrophy in Huntington's disease and progressive supranuclear palsy. Acta Neuropathol. (Berl.) 85 (1993) 553-559
37. Marder K., Zhao H., Myers R.H., Cudkowicz M., Kayson E., Kieburtz K., et al. Rate of functional decline in Huntington's disease. Huntington Study Group. Neurology 54 (2000) 452-458
38. Markianos M., Panas M., Kalfakis N., and Vassilopoulos D. Plasma testosterone in male patients with Huntington's disease: relations to severity of illness and dementia. Ann. Neurol. 57 (2005) 520-525
39. 18F]dopa metabolism in the striatum in Parkinson's disease. Brain 119 (1996) 2097-2103
40. Murray L.L., and Lenz L.P. Productive syntax abilities in Huntington's and Parkinson's diseases. Brain Cogn. 46 (2001) 213-219
41. Reiner A., Albin R.L., Anderson K.D., D'Amato C.J., Penney J.B., and Young A.B. Differential loss of striatal projection neurons in Huntington disease. Proc. Natl. Acad. Sci. U. S. A. 85 (1988) 5733-5737
42. Riviere D., Papadopoulos-Orfanos D., Poupon C., Poupon F., Coulon O., Poline J.B., Frouin V., Regis J., and Mangin J.F. A structural browser for human brain mapping. Proc. 6th HBM. NeuroImage 11 (5) (2000) 912 San Antonio, TX
43. Rosas H.D., Goodman J., Chen Y.I., Jenkins B.G., Kennedy D.N., Makris N., et al. Striatal volume loss in HD as measured by MRI and the influence of CAG repeat. Neurology 57 (2001) 1025-1028
44. Rosas H.D., Liu A.K., Hersch S., Glessner M., Ferrante R.J., Salat D.H., et al. Regional and progressive thinning of the cortical ribbon in Huntington's disease. Neurology 58 (2002) 695-701
45. Rosas H.D., Koroshetz W.J., Chen Y.I., Skeuse C., Vangel M., Cudkowicz M.E., et al. Evidence for more widespread cerebral pathology in early HD: an MRI-based morphometric analysis. Neurology 60 (2003) 1615-1620
46. Shoulson I., and Fahn S. Huntington disease: clinical care and evaluation. Neurology 29 (1979) 1-3
47. Sieradzan K.A., Mechan A.O., Jones L., Wanker E.E., Nukina N., and Mann D.M. Huntington's disease intranuclear inclusions contain truncated, ubiquitinated huntingtin protein. Exp. Neurol. 156 (1999) 92-99
48. Sprengelmeyer R., Young A.W., Calder A.J., Karnat A., Lange H., Homberg V., et al. Loss of disgust. Perception of faces and emotions in Huntington's disease. Brain 119 Pt. 5 (1996) 1647-1665
49. Steen R.G., Gronemeyer S.A., and Taylor J.S. Age-related changes in proton T1 values of normal human brain. J. Magn. Reson. Imaging 5 (1995) 43-48
50. Testa C., Laakso M.P., Sabattoli F., Rossi R., Beltramello A., Soininen H., et al. A comparison between the accuracy of voxel-based morphometry and hippocampal volumetry in Alzheimer's disease. J. Magn. Reson. Imaging 19 (2004) 274-282
51. Thieben M.J., Duggins A.J., Good C.D., Gomes L., Mahant N., Richards F., et al. The distribution of structural neuropathology in pre-clinical Huntington's disease. Brain 125 (2002) 1815-1828
52. Unified Huntington's Disease Rating Scale. Reliability and consistency. Huntington Study Group. Mov. Disord. 11 (1996) 136-142
53. Vonsattel J.P., and DiFiglia M. Huntington disease. J. Neuropathol. Exp. Neurol. 57 (1998) 369-384
54. Vonsattel J.P., Myers R.H., Stevens T.J., Ferrante R.J., Bird E.D., and Richardson E.P. Neuropathological classification of Huntington's disease. J. Neuropathol. Exp. Neurol. 44 (1985) 559-577
55. Wurtz R.H., and Hikosaka O. Role of the basal ganglia in the initiation of saccadic eye movements. Prog. Brain Res. 64 (1986) 175-190